AXDX Stock - Accelerate Diagnostics, Inc.
Unlock GoAI Insights for AXDX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $11.70M | $12.06M | $12.75M | $11.78M | $11.16M |
| Gross Profit | $2.70M | $2.55M | $3.30M | $-381,000 | $4.46M |
| Gross Margin | 23.1% | 21.1% | 25.9% | -3.2% | 39.9% |
| Operating Income | $-35,310,000 | $-54,028,000 | $-62,805,000 | $-71,560,000 | $-63,700,000 |
| Net Income | $-50,045,000 | $-61,618,000 | $-62,493,000 | $-77,702,000 | $-78,208,000 |
| Net Margin | -427.8% | -511.0% | -490.1% | -659.5% | -700.5% |
| EPS | $-2.15 | $-4.94 | $-7.61 | $-12.59 | $-13.96 |
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Visit WebsiteEarnings History & Surprises
AXDXEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 5, 2025 | — | — | — | — |
Q3 2025 | Aug 6, 2025 | — | — | — | — |
Q1 2025 | Mar 21, 2025 | — | $-0.41 | — | — |
Q1 2025 | Mar 20, 2025 | $-0.50 | $-0.37 | +26.0% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $-0.47 | $-0.59 | -25.5% | ✗ MISS |
Q3 2024 | Aug 8, 2024 | $-0.55 | $-0.53 | +3.6% | ✓ BEAT |
Q2 2024 | May 8, 2024 | $-0.72 | $-0.88 | -22.2% | ✗ MISS |
Q1 2024 | Mar 28, 2024 | $-0.62 | $-0.81 | -30.6% | ✗ MISS |
Q4 2023 | Nov 9, 2023 | $-0.94 | $-0.92 | +2.1% | ✓ BEAT |
Q3 2023 | Aug 10, 2023 | $-1.50 | $-2.36 | -57.3% | ✗ MISS |
Q2 2023 | May 11, 2023 | $-1.70 | $-1.70 | 0.0% | = MET |
Q1 2023 | Mar 29, 2023 | $-1.60 | $-1.40 | +12.5% | ✓ BEAT |
Q1 2023 | Mar 3, 2023 | — | $-1.91 | — | — |
Q3 2022 | Aug 15, 2022 | $-0.28 | $-2.40 | -757.1% | ✗ MISS |
Q2 2022 | May 16, 2022 | $-3.20 | $-2.50 | +21.9% | ✓ BEAT |
Q1 2022 | Mar 8, 2022 | $-3.00 | $-2.30 | +23.3% | ✓ BEAT |
Q4 2021 | Nov 9, 2021 | $-3.50 | $-1.50 | +57.1% | ✓ BEAT |
Q3 2021 | Aug 5, 2021 | $-3.50 | $-3.60 | -2.9% | ✗ MISS |
Q2 2021 | May 6, 2021 | $-3.30 | $-4.10 | -24.2% | ✗ MISS |
Q1 2021 | Feb 23, 2021 | $-3.10 | $-3.30 | -6.5% | ✗ MISS |
Latest News
Frequently Asked Questions about AXDX
What is AXDX's current stock price?
What is the analyst price target for AXDX?
What sector is Accelerate Diagnostics, Inc. in?
What is AXDX's market cap?
Does AXDX pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to AXDX for comparison